Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Top Cited Papers
- 21 June 2002
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 296 (5576) , 2238-2243
- https://doi.org/10.1126/science.1072613
Abstract
Huntington's disease (HD) is an inherited neurodegenerative disease caused by expansion of a polyglutamine tract in the huntingtin protein. Transcriptional dysregulation has been implicated in HD pathogenesis. Here, we report that huntingtin interacts with the transcriptional activator Sp1 and coactivator TAFII130. Coexpression of Sp1 and TAFII130 in cultured striatal cells from wild-type and HD transgenic mice reverses the transcriptional inhibition of the dopamine D2 receptor gene caused by mutant huntingtin, as well as protects neurons from huntingtin-induced cellular toxicity. Furthermore, soluble mutant huntingtin inhibits Sp1 binding to DNA in postmortem brain tissues of both presymptomatic and affected HD patients. Understanding these early molecular events in HD may provide an opportunity to interfere with the effects of mutant huntingtin before the development of disease symptoms.Keywords
This publication has 35 references indexed in Scilit:
- Cell-Type-Specific Expression of the TFIID Component TAFII135 in the Nervous SystemExperimental Cell Research, 2001
- Transcriptional dysregulation in Huntington’s diseaseTrends in Neurosciences, 2000
- Assembly of Partial TFIID Complexes in Mammalian Cells Reveals Distinct Activities Associated with Individual TATA Box-binding Protein-associated FactorsPublished by Elsevier ,2000
- Glutamine Repeats and NeurodegenerationAnnual Review of Neuroscience, 2000
- Genetic Dissection of hTAFII130 Defines a Hydrophobic Surface Required for Interaction with Glutamine-rich ActivatorsPublished by Elsevier ,1999
- Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeatsHuman Molecular Genetics, 1998
- Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregatesNature Genetics, 1998
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's diseaseAnnals of Neurology, 1996
- Mechanism of transcriptional activation by Sp1: Evidence for coactivatorsCell, 1990